• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌预测工具的批判性评价。

Critical review of prostate cancer predictive tools.

机构信息

Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Future Oncol. 2009 Dec;5(10):1555-84. doi: 10.2217/fon.09.121.

DOI:10.2217/fon.09.121
PMID:20001796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2933457/
Abstract

Prostate cancer is a very complex disease, and the decision-making process requires the clinician to balance clinical benefits, life expectancy, comorbidities and potential treatment-related side effects. Accurate prediction of clinical outcomes may help in the difficult process of making decisions related to prostate cancer. In this review, we discuss attributes of predictive tools and systematically review those available for prostate cancer. Types of tools include probability formulas, look-up and propensity scoring tables, risk-class stratification prediction tools, classification and regression tree analysis, nomograms and artificial neural networks. Criteria to evaluate tools include discrimination, calibration, generalizability, level of complexity, decision analysis and ability to account for competing risks and conditional probabilities. The available predictive tools and their features, with a focus on nomograms, are described. While some tools are well-calibrated, few have been externally validated or directly compared with other tools. In addition, the clinical consequences of applying predictive tools need thorough assessment. Nevertheless, predictive tools can facilitate medical decision-making by showing patients tailored predictions of their outcomes with various alternatives. Additionally, accurate tools may improve clinical trial design.

摘要

前列腺癌是一种非常复杂的疾病,临床决策需要平衡临床获益、预期寿命、合并症和潜在的治疗相关副作用。准确预测临床结局有助于指导前列腺癌相关决策这一艰难过程。在这篇综述中,我们讨论了预测工具的属性,并对前列腺癌相关的预测工具进行了系统综述。工具类型包括概率公式、查找表和倾向评分表、风险分层预测工具、分类和回归树分析、列线图和人工神经网络。评估工具的标准包括区分度、校准度、可推广性、复杂程度、决策分析和处理竞争风险和条件概率的能力。本文描述了现有的预测工具及其特征,重点介绍了列线图。虽然一些工具校准良好,但很少有工具经过外部验证或与其他工具直接比较。此外,应用预测工具的临床后果需要进行全面评估。尽管如此,预测工具可以通过向患者展示针对各种治疗方案的个体化预后预测来帮助临床决策。此外,准确的工具可能会改善临床试验设计。

相似文献

1
Critical review of prostate cancer predictive tools.前列腺癌预测工具的批判性评价。
Future Oncol. 2009 Dec;5(10):1555-84. doi: 10.2217/fon.09.121.
2
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.对基于逻辑回归的列线图、人工神经网络、分类与回归树模型、查找表以及前列腺癌风险组分层模型的批判性评估。
BJU Int. 2007 Apr;99(4):794-800. doi: 10.1111/j.1464-410X.2006.06694.x.
3
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.列线图与其他预测前列腺癌预后方法的比较:文献的批判性分析
Clin Cancer Res. 2008 Jul 15;14(14):4400-7. doi: 10.1158/1078-0432.CCR-07-4713.
4
An updated catalog of prostate cancer predictive tools.前列腺癌预测工具的最新目录。
Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908.
5
Decision-making tools in prostate cancer: from risk grouping to nomograms.前列腺癌的决策工具:从风险分组到列线图
Minerva Urol Nefrol. 2017 Dec;69(6):556-566. doi: 10.23736/S0393-2249.17.02832-6. Epub 2017 Mar 30.
6
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.联合临床参数和多参数磁共振成像预测前列腺外疾病-用于计划根治性前列腺切除术时患者个体化风险分层的风险模型。
Eur Urol Focus. 2020 Nov 15;6(6):1205-1212. doi: 10.1016/j.euf.2018.11.004. Epub 2018 Nov 23.
7
Predictive models before and after radical prostatectomy.根治性前列腺切除术前后的预测模型。
Prostate. 2010 Sep 1;70(12):1371-8. doi: 10.1002/pros.21159.
8
Use of nomograms for predictions of outcome in patients with advanced bladder cancer.应用列线图预测晚期膀胱癌患者的预后。
Ther Adv Urol. 2009 Apr;1(1):13-26. doi: 10.1177/1756287209103923.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.局部前列腺癌生存质量评估工具和预测工具的临床应用:一项全国范围内对放射肿瘤学家和泌尿科医生的调查结果。
J Urol. 2013 Jun;189(6):2092-8. doi: 10.1016/j.juro.2012.11.174. Epub 2012 Dec 3.

引用本文的文献

1
Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer.雄激素受体和骨形成蛋白聚糖基因表达预测转移性前列腺癌的预后
Sci Rep. 2024 Dec 28;14(1):30654. doi: 10.1038/s41598-024-74443-z.
2
Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy.尿液生物标志物可预测前列腺癌和活检前的 PI-RADS 评分。
Sci Rep. 2024 Aug 5;14(1):18148. doi: 10.1038/s41598-024-68026-1.
3
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review.血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值在非转移性和转移性前列腺癌患者中的预后作用:一项荟萃分析和系统评价
Asian J Urol. 2024 Apr;11(2):191-207. doi: 10.1016/j.ajur.2023.01.002. Epub 2023 Feb 6.
4
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer.阳性家族史作为非转移性前列腺癌根治性前列腺切除术后疾病预后的预测指标。
Arab J Urol. 2023 Apr 3;21(4):241-247. doi: 10.1080/2090598X.2023.2196911. eCollection 2023.
5
Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma.基于七个内质网应激相关 lncRNAs 的头颈部鳞状细胞癌患者预后标志物的构建和验证。
Sci Rep. 2023 Dec 16;13(1):22414. doi: 10.1038/s41598-023-49987-1.
6
Evaluation of comprehensive complication index versus Clavien-Dindo classification in prediction of overall survival after radical cystectomy.根治性膀胱切除术后综合并发症指数与Clavien-Dindo分类法对总生存预测的评估
Int Urol Nephrol. 2023 Jun;55(6):1459-1465. doi: 10.1007/s11255-023-03564-7. Epub 2023 Mar 26.
7
Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate Cancer.非转移性和转移性前列腺癌患者血小板与淋巴细胞、中性粒细胞与淋巴细胞和白蛋白与球蛋白比值的前瞻性对比分析。
Curr Oncol. 2022 Dec 3;29(12):9474-9500. doi: 10.3390/curroncol29120745.
8
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review.白蛋白与球蛋白比值在非转移性和转移性前列腺癌患者中的预后价值:一项荟萃分析和系统评价。
Int J Mol Sci. 2022 Sep 29;23(19):11501. doi: 10.3390/ijms231911501.
9
Joint models for dynamic prediction in localised prostate cancer: a literature review.局部前列腺癌动态预测的联合模型:文献综述。
BMC Med Res Methodol. 2022 Sep 19;22(1):245. doi: 10.1186/s12874-022-01709-3.
10
A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery.上尿路尿路上皮癌手术后预后列线图的系统评价与Meta分析
Front Oncol. 2022 Jul 1;12:907975. doi: 10.3389/fonc.2022.907975. eCollection 2022.

本文引用的文献

1
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
2
Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.治疗前生物标志物水平可提高前列腺切除术后列线图预测生化复发的准确性。
Prostate. 2009 Jun 1;69(8):886-94. doi: 10.1002/pros.20938.
3
Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers.用于评估诊断试验、预测模型和分子标志物的决策分析。
Am Stat. 2008;62(4):314-320. doi: 10.1198/000313008X370302.
4
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.决策曲线分析的扩展,一种评估诊断试验、预测模型和分子标志物的新方法。
BMC Med Inform Decis Mak. 2008 Nov 26;8:53. doi: 10.1186/1472-6947-8-53.
5
Can nomograms be superior to other prediction tools?列线图能否优于其他预测工具?
BJU Int. 2009 Feb;103(4):492-5; discussion 495-7. doi: 10.1111/j.1464-410X.2008.08073.x. Epub 2008 Sep 18.
6
An updated catalog of prostate cancer predictive tools.前列腺癌预测工具的最新目录。
Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908.
7
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.列线图与其他预测前列腺癌预后方法的比较:文献的批判性分析
Clin Cancer Res. 2008 Jul 15;14(14):4400-7. doi: 10.1158/1078-0432.CCR-07-4713.
8
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.通过一组术前血液生物标志物改善前列腺癌根治术后疾病复发的预测
Clin Cancer Res. 2008 Jun 15;14(12):3785-91. doi: 10.1158/1078-0432.CCR-07-4969.
9
Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma.开发一种用于预测肾外伤患者是否需要进行探查的高精度列线图。
J Trauma. 2008 Jun;64(6):1451-8. doi: 10.1097/TA.0b013e3181271b77.
10
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.术前血浆内皮糖蛋白水平可预测根治性前列腺切除术后的生化进展。
Clin Cancer Res. 2008 Jun 1;14(11):3362-6. doi: 10.1158/1078-0432.CCR-07-4707.